Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
NewsWire
|
Shire, a specialty biopharmaceutical company, has reported that net income for the first quarter ended March 31, 2013 was $64.8 million, or 35.1 cents per diluted share, compared to $238.4 million, or 124.2 cents per diluted share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Celldex Therapeutics, Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $17.33 million, or $0.23 loss per share, compared to a net loss of $13.52 million, or $0.27 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
QLT Inc., a biotechnology company, has reported that net loss for the first quarter ended March 31, 2013 was $6.43 million, or $0.13 loss per share, compared to a net loss of $10.28 million, or $0.21 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Soligenix, Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $1.09 million, or $0.10 loss per share, compared to a net loss of $1.44 million, or $0.13 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Netsmart Technologies, Inc., a provider of clinical solutions for health and human services organizations, has appointed Ian Chuang as senior vice president, healthcare informatics and chief medical officer.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Eventus Diagnostics, Inc., a developer of immune-based blood tests for the detection of cancer, has received CE mark designation for its Octava Pink breast cancer test intended for confirmatory use in women who have received negative mammography results.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Cardinal Health, Inc., a healthcare services company, has reported that net earnings for the third quarter ended March 31, 2013 were $345 million, or $1.00 per diluted share, compared to $333 million, or $0.95 per diluted share, for the same quarter ended March 31, 2012. The company expects non-GAAP diluted EPS from continuing operations to be in the range of $3.67 to $3.71 for fiscal 2013.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Zalicus Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $8.05 million, or $0.06 loss per share, compared to a net loss of $13.54 million, or $0.13 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Repligen Corporation, a life sciences company developing products for monoclonal antibody-based therapeutics, has reported that net income for the first quarter ended March 31, 2013 was $2.34 million, or $0.07 per share, compared to $1.23 million, or $0.04 per share, for the same quarter ended March 31, 2012. The company expects net income to be in the range of $18 to $20 million for 2013.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc., has entered into an agreement with Fillmore County Hospital to deploy NextGen Inpatient Clinicals and NextGen Inpatient Financials across its enterprise to improve care for local patients and improve efficiency within the organization.
Published By MarketLine
|
16 May 2013 |
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.